Cargando…
Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome
Rett syndrome (RTT), caused by loss-of-function mutations in the MECP2 gene, is a neurological disorder characterized by severe impairment of motor and cognitive functions. The aim of this study was to investigate the impact of vector design, dosage, and delivery route on the efficacy and safety of...
Autores principales: | Gadalla, Kamal K.E., Vudhironarit, Thishnapha, Hector, Ralph D., Sinnett, Sarah, Bahey, Noha G., Bailey, Mark E.S., Gray, Steven J., Cobb, Stuart R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423329/ https://www.ncbi.nlm.nih.gov/pubmed/28497075 http://dx.doi.org/10.1016/j.omtm.2017.04.007 |
Ejemplares similares
-
Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery
por: Sinnett, Sarah E., et al.
Publicado: (2017) -
Gait Analysis in a Mecp2 Knockout Mouse Model of Rett Syndrome Reveals Early-Onset and Progressive Motor Deficits
por: Gadalla, Kamal K. E., et al.
Publicado: (2014) -
Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes
por: Ross, Paul D., et al.
Publicado: (2016) -
Radically truncated MeCP2 rescues Rett syndrome-like neurological defects
por: Tillotson, Rebekah, et al.
Publicado: (2017) -
Potential Toxic Effect of Bisphenol A on the Cardiac Muscle of Adult Rat and the Possible Protective Effect of Omega-3: A Histological and Immunohistochemical Study
por: Bahey, Noha Gamal, et al.
Publicado: (2019)